BioCardia, Inc.

BioCardia, Inc.verified

BCDA

Price:

$0.88

Market Cap:

$5.10M

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for ...[Read more]

Industry

Biotechnology

IPO Date

1996-11-13

Stock Exchange

NASDAQ

Ticker

BCDA

The Enterprise Value as of June 2026 (TTM) for BioCardia, Inc. (BCDA) is 4.56M

According to BioCardia, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.56M. This represents a change of -50.79% compared to the average of 9.28M of the last 4 quarters.

BioCardia, Inc. (BCDA) Historical Enterprise Value (quarterly & annually)

How has BCDA Enterprise Value performed in the past?

The mean historical Enterprise Value of BioCardia, Inc. over the last ten years is 105.34M. The current 4.56M Enterprise Value has changed 333.26% with respect to the historical average. Over the past ten years (40 quarters), BCDA's Enterprise Value was at its highest in in the June 2017 quarter at 891.47M. The Enterprise Value was at its lowest in in the September 2025 quarter at 3.45M.

Quarterly (TTM)
Annual

Average

105.34M

Median

85.85M

Minimum

4.56M

Maximum

304.14M

BioCardia, Inc. (BCDA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioCardia, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 45.56%

Maximum Annual Enterprise Value = 304.14M

Minimum Annual Increase = -8381.39%

Minimum Annual Enterprise Value = 4.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20256.37M39.54%
20244.56M-68.04%
202314.28M-86.45%
2022105.34M20.43%
202187.47M3.84%
202084.24M45.56%
201957.87M-56.42%
2018132.80M-48.19%
2017256.34M-15.71%
2016304.14M-8381.39%

BioCardia, Inc. (BCDA) Average Enterprise Value

How has BCDA Enterprise Value performed in the past?

The current Enterprise Value of BioCardia, Inc. (BCDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.40M

5-year avg

43.60M

10-year avg

105.34M

BioCardia, Inc. (BCDA) Enterprise Value vs. Peers

How is BCDA’s Enterprise Value compared to its peers?

BioCardia, Inc.’s Enterprise Value is greater than Creative Medical Technology Holdings, Inc. (-123148.00), greater than Aprea Therapeutics, Inc. (-42010310.00), greater than Acurx Pharmaceuticals, Inc. (-6766398.00), greater than Kiora Pharmaceuticals, Inc. (719.67K), less than HCW Biologics Inc. (8.02M), greater than Alzamend Neuro, Inc. (1.09M), greater than Adial Pharmaceuticals, Inc. (-1724361.00), greater than IN8bio, Inc. (-12958522.00), greater than Phio Pharmaceuticals Corp. (-4600542.00), less than Aptevo Therapeutics Inc. (8.24M),

Build a custom stock screener for BioCardia, Inc. (BCDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCardia, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCardia, Inc. (BCDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCardia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioCardia, Inc.'s Enterprise Value?

What is the highest Enterprise Value for BioCardia, Inc. (BCDA)?

What is the 3-year average Enterprise Value for BioCardia, Inc. (BCDA)?

What is the 5-year average Enterprise Value for BioCardia, Inc. (BCDA)?

How does the current Enterprise Value for BioCardia, Inc. (BCDA) compare to its historical average?